Philips will unveil a new mixed reality concept developed together with Microsoft that the company says is designed for the operating room of the future. Based on Philips’ Azurion image-guided therapy platform and Microsoft’s HoloLens 2 holographic computing platform, the companies will showcase novel augmented reality applications for image-guided minimally invasive therapies. The technology will debut at Mobile World Congress (MWC) Barcelona, Feb. 25-28 in Barcelona, Spain.
Imaging Technology News has been recognized with three award nominations from the Jesse H. Neal Awards as a finalist for ...
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at the ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ...
Agfa Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its DR 800 multipurpose digital radiography (DR) imaging system with tomosynthesis. Offering one solution for radiography, fluoroscopy, multi-slice and advanced clinical applications, the DR 800 supports the role of radiology in the value-based care organization with increased versatility, functionality and efficiency.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Welch Road Imaging in California recently became the first RamSoft customer to integrate openDoctor with its PowerServer radiology information system (RIS)/picture archiving and communication system (PACS). With openDoctor, PowerServer RIS/PACS sends reminders and instructions regarding imaging appointments to patients via email, text and voice.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable minimally invasive biopsy in the peripheral lung.
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the ...
The boards of Are You Dense Inc. and Are You Dense Advocacy Inc., founded by the late Nancy M. Cappello, Ph.D., announced her husband Joseph J. Cappello as their new executive director. For over a decade, Joseph has worked side-by-side as co-founder of the organizations with his wife, earning him a unique perspective of the critical issue on adjunct screening for women with dense breast tissue.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
At RSNA 2018, Philips Healthcare introduced Performance Bridge as an integral part of its IntelliSpace Enterprise ...
Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the DigitalDiagnost C90, its newest premium digital radiography (DR) system. Designed to increase patient throughput and decrease the time to diagnosis, the Philips DigitalDiagnost C90 offers healthcare organizations a flexible and customizable imaging solution that helps to improve workflow and clinical outcomes, while adding economic value.
In a just-published Journal of Biomechanics article, the researchers proved a longtime assumption about individuals' right and left wrists, while also finding differences between wrists of males and females. These discoveries could help inform and guide future treatments.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by ...
As part of a federal spending bill passed late Friday, Congress directed the U.S. Food and Drug Administration (FDA) to establish a national minimum standard for including fibroglandular breast density information on mammography reports. While 36 states have already enacted their own breast density inform legislation, the federal version will ensure that every state takes a minimum level of action on making patients aware of the increased breast cancer risk associated with dense breasts.
February 18, 2019 — Mirada Medical Ltd announced U.S. Food and Drug Administration (FDA) 510(k) clearance for ...
Below are photos from the Healthcare Information Management and Systems Society (HIMSS) 2019 meeting Feb. 11-16 in ...
Philips announced the launch of Philips Zenition, its new mobile C-arm imaging platform. Mobile C-arms are X-ray systems that are brought into the operating room (OR) to provide live image guidance during a wide range of surgeries including orthopedic, trauma and vascular procedures. The Zenition mobile C-arm platform brings together innovations in image capture, image processing, ease-of-use and versatility pioneered on Philips’ Azurion platform. Zenition allows hospitals to maximize OR performance, enhance their clinical capabilities and offer their staff a high-quality user experience. Zenition will be introduced in the U.S., Germany, Austria and Switzerland in the first half of 2019, and will subsequently be rolled out in further markets.
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows developers to process unstructured medical text and identify information such as patient diagnosis, treatments, dosages, symptoms and signs, and more. Comprehend Medical helps improve clinical decision support, streamline revenue cycle and clinical trials management, and better address data privacy and protected health information (PHI) requirements.
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the ...
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new approach to treating recurrent brain tumors. GammaTile Therapy is a U.S. Food and Drug Administration (FDA)-cleared, surgically targeted radiation therapy (STaRT) manufactured by GT Medical Technologies that is designed to delay tumor regrowth for patients with brain tumors.